Safety of osimertinib for advanced non-small cell lung cancer with EGFR mutation: an overview of systematic reviews

FAN Chunling, CHEN Yuyan, XU Ying, HUANG Yanhui, MIN Qiong

Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (4) : 432-440.

PDF(689 KB)
PDF(689 KB)
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (4) : 432-440. DOI: 10.13286/j.1001-5213.2024.04.11
Drug and Clinical

Safety of osimertinib for advanced non-small cell lung cancer with EGFR mutation: an overview of systematic reviews

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(4): 432-440 https://doi.org/10.13286/j.1001-5213.2024.04.11

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(689 KB)

Accesses

Citation

Detail

Sections
Recommended

/